Ventilation and Gastric Insufflation During Three Levels of Inspiratory Pressure During Mask Ventilation

Evaluation of Adequacy of Ventilation and Gastric Insufflation During Three Levels of Inspiratory Pressure for Pressure-controlled Mask Ventilation During Induction of Anesthesia: a Randomized Controlled Study

Pulmonary aspiration of gastric contents is one of the leading causes of general anesthesia-related mortality. Gastric insufflation during positive pressure mask ventilation increases the gastric volume, and consequently the risk of regurgitation. Thus, positive pressure mask ventilation should be avoided during rapid sequence induction of anesthesia when full-stomach is suspected (e.g. inadequate fasting hours, gastrointestinal obstruction, delayed gastric emptying, and lower esophageal disease) Although avoidance of positive pressure mask ventilation during induction would potentially minimize the risk of aspiration, this would lead to rapid hypoxia . Hence, finding a proper regimen for mask ventilation would avoid hypoxia which might be serious in high-risk patients.

Pressure-controlled face mask ventilation previously proved to be the least regimen to cause gastric insufflation in comparison to manual, and volume-controlled mask ventilation during induction of anesthesia. Later, a pressure of 15 cmH2O during face mask ventilation had been reported optimum to achieve the balance between adequate ventilation and reduced gastric insufflation in non-paralyzed patients. This finding was not yet replicated in paralyzed patients who represent the majority of population who receive mask ventilation during induction of anesthesia. We hypothesize that in paralyzed patient, the optimum pressure during face mask ventilation might be lower than the pressure which was previously reported in non-paralyzed patients. However, no studies to the best of our knowledge had confirmed this hypothesis.

Gastric insufflation was previously evaluated using auscultation with stethoscope, microphone placed in the epigastric area, or esophageal manometry. Recently, gastric antrum ultrasound was used successfully to gastric insufflation in real time by measuring the cross sectional area of gastric antrum before and after face mask ventilation. This newly developed method is more sensitive than the auscultatory method and less invasive than esophageal manometry method.

Study Overview

• Status: Recruiting
• Conditions: Gastric Insufflation; Mask Ventilation; Gastric Ultrasonography
• Intervention / Treatment: Other: peak inspiratory pressure 10 cmH2O; Other: peak inspiratory pressure 15 cmH2O; Other: peak inspiratory pressure 20 cmH2O

Detailed Description

Upon arrival to the operating room, routine monitors (ECG, pulse oximetry, and non-invasive blood pressure monitor) will be applied, intravenous line will be secured, and routine pre-medications (ranitidine 50 mg and midazolam 3-5 mg) will be administrated. End-tidal CO2 monitoring will be initiated after induction of general anesthesia and starting face-mask ventilation. Induction of anesthesia will be achieved using fentanyl (2 mcg/Kg), propofol (2 mg/Kg), and rocuronium (0.6 mg/Kg). After loss of verbal response, mask ventilation will be achieved by appropriate size face mask and oropharyngeal airway with 100% oxygen and double hand jaw thrust head tilt maneuver. The included patients will be randomly allocated to receive the assigned pressure-controlled mask ventilation. The 3 study groups will receive the planned inspiratory pressure, without positive end-expiratory pressure, with a respiratory rate of 15, and inspiratory to expiratory ratio of 1:2 for 180 seconds.

Assessment gastric insufflation during mask ventilation will be achieved by ultrasound assessment of gastric antrum (in the sagittal plane between left lobe of the liver and pancreas at level of the aorta) and auscultation by two blinded investigators to the assigned pressure. The ultrasound screen will be positioned to be not visible to the investigator responsible for auscultation. Gastric insufflation will be identified by comet-tail sign by gastric ultrasound and gurgling sound by auscultation.

Gastric antrum cross sectional area [ D1(longitudinal diameter) X D2 (anteroposterior diameter) X π /4] in between contractions in supine position before face mask ventilation and after insertion of endotracheal tube will be recorded. gastric insufflation will be identified if gastric antrum cross sectional area increased by > 30% after endotracheal intubation in relation to the baseline.

During mask ventilation, the following parameter will be recorded at 30, 60, 90,120, 150 and 180 seconds; peripheral oxygen saturation, the end-tidal carbon dioxide concentration , peak airway measured pressure, and tidal volume Demographic data (age, sex, weight, height, BMI, comorbidities) will be recorded.

• Study Type: Interventional
• Enrollment (Anticipated): 111
• Phase: Not Applicable

Contacts and Locations

• Study Contact: Name: ahmed hasanin, M.D; Phone Number: +2 01095076954; Email: ahmedmohamedhasanin@gmail.com

Study Locations

• Egypt
  • Cairo, Egypt, 11562
    • Recruiting
    • Kasr Alaini hospital
    • Contact: Anesthesia, Pain Management and Surgical ICU Department; Phone Number: 00201222224057; Email: Anesthesia.kasralainy@gmail.com

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

Description

Inclusion Criteria:

• adult patients (above 18 years)
• American society of anesthesiologist I-II
• scheduled for elective non-cardiac surgery under general anesthesia

Exclusion Criteria:

• increased risk of difficult mask ventilation
• patients at risk of aspiration
• Patients with craniofacial anomalies
• BMI >35 kg/m2
• pregnant patients

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Supportive Care
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: Triple

Number of Arms

3

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Active Comparator: pressure 10; mask ventilation with peak inspiratory pressure of 10 cmH2O	Other: peak inspiratory pressure 10 cmH2O; pressure controlled mask ventilation with peak inspiratory pressure of 10 cmH2O
Active Comparator: pressure 15; mask ventilation with peak inspiratory pressure of 15 cmH2O	Other: peak inspiratory pressure 15 cmH2O; pressure controlled mask ventilation with peak inspiratory pressure of 15 cmH2O
Active Comparator: pressure 20; mask ventilation with peak inspiratory pressure of 20 cmH2O	Other: peak inspiratory pressure 20 cmH2O; pressure controlled mask ventilation with peak inspiratory pressure of 20 cmH2O

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
incidence of gastric insufflation by ultrasonography	gastric antrum cross sectional area increased by > 30% after endotracheal intubation in relation to the baseline	within 1 minute after endotracheal intubation

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Gastric antrum cross sectional area	gastric antrum longitudinal diameter X anteroposterior diameter X π /4 in between contractions in supine position	1 minute before mask ventilation and within 1 minute after endotracheal intubation
tidal volume	mL	at 30, 60, 90,120, 150, and 180 seconds after onset of mask ventilation
endtidal CO2	mmHg	at 30, 60, 90,120, 150, and 180 seconds after onset of mask ventilation
peripheral O2 saturation	percentage	at 30, 60, 90,120, 150, and 180 seconds after onset of mask ventilation
incidence of gastric insufflation by auscultation	gurgling sound by stethoscope	1 minute after onset of mask ventilation

Collaborators and Investigators

• Sponsor: Kasr El Aini Hospital

Study record dates

Study Major Dates

• Study Start (Actual): September 9, 2021
• Primary Completion (Anticipated): December 1, 2021
• Study Completion (Anticipated): December 1, 2021

Study Registration Dates

• First Submitted: August 19, 2021
• First Submitted That Met QC Criteria: August 19, 2021
• First Posted (Actual): August 25, 2021

Study Record Updates

• Last Update Posted (Actual): September 13, 2021
• Last Update Submitted That Met QC Criteria: September 10, 2021
• Last Verified: September 1, 2021

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Pathologic Processes; Respiratory Tract Diseases; Respiration Disorders; Respiratory Aspiration
• Other Study ID Numbers: MD-250-2019

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No